The program features case studies in vaccine development for cancer and infectious diseases, offering insights into best practices and technological advancements. Engage in focused discussions and networking with thought leaders to understand immunotherapy innovations for cancer and autoimmune diseases. The event concludes with the release of the ‘Harnessing Vaccine Technologies & Immunotherapies with Best Practice Approaches’ report, summarizing key insights and emerging trends.
Vaccines & Immunotherapies Online Symposium again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Confirmed speakers include: Amita Vaidya, Principal Scientist from Sanofi, Brian Schanen, Global Head of Biomarkers at Sanofi, Mabrouka Maamra, Project Manager at University of Sheffield, Mats Lundgren, CSO at Abera Bioscience, Samantha Paston, Head of translational research at Scancell ltd, and Tobias von der Haar, Professor of Systems Biology at University of Kent.
Vaccines & Immunotherapies Online Symposium again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Confirmed speakers include: Amita Vaidya, Principal Scientist from Sanofi, Brian Schanen, Global Head of Biomarkers at Sanofi, Mabrouka Maamra, Project Manager at University of Sheffield, Mats Lundgren, CSO at Abera Bioscience, Samantha Paston, Head of translational research at Scancell ltd, and Tobias von der Haar, Professor of Systems Biology at University of Kent.
